%0 Journal Article %A Bretonnière, Cédric %A Jozwiak, Mathieu %A Girault, Christophe %A Beuret, Pascal %A Trouillet, Jean-Louis %A Anguel, Nadia %A Caillon, Jocelyne %A Potel, Gilles %A Villers, Daniel %A Boutoille, David %A Guitton, Christophe %D 2015 %T Additional file 1: Figure S1. of Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study %U https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Figure_S1_of_Rifampin_use_in_acute_community-acquired_meningitis_in_intensive_care_units_the_French_retrospective_cohort_ACAM-ICU_study/4467848 %R 10.6084/m9.figshare.4467848.v1 %2 https://ndownloader.figshare.com/files/7197323 %K Table S 1. Comparison %K French retrospective cohort ACAM-ICU study Bacteria %K pneumococcal meningitis %K Figure S 2. Glasgow Outcome Scale scores %K Figure S 3. Glasgow Outcome Scale scores %K community-acquired meningitis %K ICU admission %K PDF 157 kb %X Bacteria involved in 136 episodes of meningitis. Figure S2. Glasgow Outcome Scale scores for the groups of patients who did or did not receive rifampin for community-acquired meningitis. Figure S3. Glasgow Outcome Scale scores for the groups of patients who did or not receive early rifampin (within the first 24 h of hospitalization) or not for community-acquired meningitis. Table S1. Comparison of patient characteristics, severity at ICU admission, 9pt?>microbiological data, and therapeutic measures between survivors and non-survivors after ICU admission for pneumococcal meningitis (n=76). Table S2. Factors associated with ICU mortality for a cohort of 76 patients admitted for pneumococcal meningitis. (PDF 157 kb) %I figshare